Phase I trial of ACE-393 (Campylobacter jejuni vaccine)

Trial Profile

Phase I trial of ACE-393 (Campylobacter jejuni vaccine)

Phase of Trial: Phase I

Latest Information Update: 21 Mar 2014

At a glance

  • Drugs ACE 393 (Primary)
  • Indications Campylobacter infections; Traveller's diarrhoea
  • Focus Adverse reactions; Registrational
  • Sponsors ACE BioSciences
  • Most Recent Events

    • 06 Sep 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top